Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Buyang Huanwu granules
- Development stage
- Unknown
- Lead developer
- Zhejiang Chinese Medical University
- Administration
- Oral
01
Overview
Buyang Huanwu granules (BYHW) is a traditional Chinese medicine (TCM) formulation derived from the classic Buyang Huanwu decoction (BHD), which has been used for centuries to treat cardiovascular and cerebrovascular diseases. The formulation consists of seven key herbal ingredients: *Astragalus mongholicus* (Huangqi), *Angelica sinensis* (Danggui), *Paeonia lactiflora* (Chishao), *Lumbricus rubellus* (Dilong), *Ligusticum chuanxiong* (Chuanxiong), *Carthamus tinctorius* (Honghua), and *Prunus persica* (Taoren). It is primarily used to treat stable angina pectoris (SAP) in coronary heart disease and ischemic stroke, particularly in patients presenting with the TCM syndrome pattern of qi deficiency and blood stasis (QDBS). BYHW works by protecting vascular endothelial function, delaying atherosclerosis, improving hemorheology, reducing blood lipids, and exerting anti-inflammatory and antithrombotic effects.
- Other names
- Buyang Huanwu granuleBuyang Huanwu decoction granulesBYHWBHGBuyang Huanwu decoction-type formulas
02
Targets
IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)
Beyond the preview
Go deeper on Buyang Huanwu granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Buyang Huanwu granules.